Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on September 10, 2025

Digital Saudi Arabia Serves 26M Citizens, Sets Global Standard for Digital Transformation
Digital Saudi Arabia Serves 26M Citizens, Sets Global Standard for Digital Transformation RIYADH, SAUDI ARABIA, September 10, 2025 /EINPresswire.com/ -- Saudi Arabia’s rapid digital transformation has redefined how citizens access government, healthcare …

GOALisB Hosts Exclusive Q&A on ISB PGP vs PGP YL with ISB Leadership
NEW DELHI, INDIA, September 10, 2025 /EINPresswire.com/ -- GOALisB, India’s leading MBA admissions consulting platform, hosted an exclusive and high-impact webinar featuring Mr. Amit Tyagi, Senior Associate Director at the Indian School of Business (ISB …

مؤتمر وايل كورنيل للطب –قطر الثالث للبروتيوميات يسلّط الضوء على أحدث التطورات في مجالي البروتيوميات والمعلوماتية الحيوية
DOHA, DOHA, QATAR, September 10, 2025 /EINPresswire.com/ -- تُنظّم وايل كورنيل للطب – قطر المؤتمر الثالث للبروتيوميات من 13 إلى 15 أكتوبر 2025، حيث سيجتمع أبرز العلماء والباحثين والخبراء الأكاديميين المرموقين من مختلف أنحاء العالم في هذا الملتقى الحيوي، …

The 3rd WCM-Q Qatar Proteomics Conference to spotlight advances in proteomics and bioinformatics
Weill Cornell-Qatar’s 3rd Proteomics Conference unites scientists and scholars for a dynamic exchange in proteomics and bioinformatics. DOHA, QATAR, September 10, 2025 /EINPresswire.com/ -- Weill Cornell Medicine-Qatar’s 3rd Qatar Proteomics Conference …

Business Process Xperts Launches New Services in Process Consultation to Accelerate Digital Transformation
BPX expands its consulting services to drive digital transformation, reengineer processes, boost efficiency, and enable sustainable growth with automation. PUNE, MAHARASHTRA, INDIA, September 10, 2025 /EINPresswire.com/ -- One of the leading business …

Relmada Issues Mid-Year CEO Letter to Shareholders
CORAL GABLES, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology-related and central nervous system indications, …

Phononic Announces Exclusive Cold Chain Licensing Agreement with Peltier, Inc.
DURHAM, N.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Phononic, the global leader in solid state cooling technology, has entered into a strategic exclusive cold chain licensing agreement with Peltier Technology, Inc. Phononic’s Active Cooling Solutions (ACS™) …

Purespring Therapeutics to Participate in the 2025 BofA Healthcare Trailblazers Private Company Conference
London – 10 September 2025 - Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, today announced that members of its management team will participate in the 2025 Bank of America Healthcare …

Sagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development Summit
SAN MATEO, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that …

Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)
ORR of 35% in previously treated squamous NSCLC patients with responses across PD-L1 TPS scores Differentiated structure of ‘2510 potentially results in best-in-class monotherapy activity in 2L+ NSCLC for PD-(L)1xVEGF bispecifics DALLAS, Sept. 10, 2025 ( …

CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
Oversubscribed Financing led by Coastlands Capital with participation from new and existing investors Financing to provide $50 million in upfront proceeds with the potential for up to an additional $50 million of proceeds to fund the Phase 1/2 clinical …

PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
PYNNACLE Phase 2 pivotal clinical trial interim data include confirmed responses observed in eight tumor types spanning ovarian, lung, breast, endometrial, head and neck, colorectal, gallbladder, and ampullary carcinoma 33% overall response rate (ORR) …

Backed by Four Decades of Executive Recruiting Expertise, Marovi Launches to Transform the Way Leaders Are Hired
ATLANTA , Sept. 10, 2025 (GLOBE NEWSWIRE) -- Being officially unveiled for the first time at next week’s HR Tech 2025, Marovi will take center stage to showcase how it transforms the previously staid category of executive hiring. Founded by a team with …

Lantronix Wins Leading Industry Product of the Year Award for Innovative Solutions in Drone Development
IRVINE, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced that its TAA/NDAA-compliant Open-Q™ System-on-Module (SOM) that is …

Immuneering to Announce Updated Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on September 25
- Company plans to host an investor call at 8 a.m. ET on September 25 - - Immuneering plans to then share the updated data at the PanCAN Scientific Summit on September 28 - - Additionally, the Company will present a review of preclinical data on Deep …

Aduro Clean Technologies to Participate in September Technical Conferences Across Europe and North America
LONDON, Ontario, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste …

Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Obagi® saypha® MagIQ™ injectable hyaluronic acid (“ …

AI-Media erweitert die LEXI Suite mit LEXI Voice, LEXI Direct API und LEXI AD (Audio Description) auf der IBC 2025 in Amsterdam
LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- AI-Media (ASX: AIM), der weltweit führende Anbieter von KI-gestützten Sprachlösungen, wird seine bahnbrechende LEXI Voice-Plattform auf der IBC 2025 (Stand 5.C33, 12.–15. September, RAI Amsterdam) vorstellen und …

AI-Media amplía la suite LEXI con LEXI Voice, LEXI Direct API y LEXI AD (Autodescripción) en IBC 2025 en Ámsterdam
LONDRES, Sept. 10, 2025 (GLOBE NEWSWIRE) -- AI-Media (ASX: AIM), líder mundial en soluciones lingüísticas impulsadas por inteligencia artificial, presentará su plataforma innovadora LEXI Voice en IBC 2025 (Stand 5.C33, del 12 al 15 de septiembre, RAI …

AI-Media תציג את ההרחבה של LEXI Suite עם LEXI Voice, LEXI Direct API ו-LEXI AD (Audio Description) במהלך IBC 2025 באמסטרדם
לונדון, Sept. 10, 2025 (GLOBE NEWSWIRE) -- AI-Media (ASX: AIM), מובילה עולמית בפתרונות שפה מבוססי בינה מלאכותית, תציג את פלטפורמת LEXI Voice פורצת הדרך שלה ב-IBC 2025 (ביתן 5.C33, בין ה-12-15 בספטמבר, ב-RAI אמסטרדם), לציון ההשקה הרשמית של הפתרון לשוק …